Acute Heart Failure Clinical Trial
Official title:
Evaluation of Acute Cardiogenic Dyspnoea With Thorax Echography and Pro-BNP in the Emergency Department
LUNG ULTRASOUND IN THE MANAGEMENT OF DISPNEIC PATIENTS IN EMERGENCY DEPARTMENT
Introduction
This is a prospective randomized trial realized in the Emergency Department of the
University Hospital of Siena, Italy.
Dyspnea is one of the most common causes worldwide of admission to the Emergency Department
(ED) and acute heart failure (AHF) is a major cause of serious morbidity and death in such
population, above all in elderly patients. Incidence rate is significantly higher in men than
in women, in Europe it increases with age from 1.4/1000 person-years in subjects aged 55-59
years to 47.4/1000 person-years in those aged 90 years or older. The age-adjusted prevalence
of AHF in the United States averages 36 cases per 100,000 of the population and accounts for
10,000 deaths annually.
In clinical practice this symptomatology is usually investigated in the pre-hospital phase
only with history and physical examination; in the ED blood gas analysis (BGA), laboratory
tests and chest X-rays can be performed as primary exams. BNP and NT pro-BNP are now
considered reliable biochemical markers to distinguish cardiogenic from pulmonary etiology,
both for their diagnostic and prognostic value. On the other hand, these biomarkers are
affected by a "grey zone" of uncertainty, they are not available in all hospitals and their
dosage samples are expensive: thus we propose other tools to support the diagnostic process.
THE RATIONALE OF THE STUDY
It is widely reported in literature that ultrasound can identify the presence of
interstitial and pulmonary alveolar syndrome by comet tail artifact with good sensitivity
and specificity. This is an easy technique to perform and interpret, readily available and
repeatable over time and executable bedside even in emergency situations. The execution of
this investigative technique in the ED and also in a pre-hospital setting would provide
additional and reliable information for patients with dyspnea, so favoring rapid
identification of the etiology.
Accepting these observations, lung ultrasound (LUS) could have a central role in the
evaluation of patients with shortness of breath in ED. Even the LUS in many studies has been
considered useful for detecting pulmonary alterations, there are few data regarding its
utilization in clinical practice and there is a lack of evidences concerning validated
operative protocols. On this basis, it was decided to evaluate the employment of LUS in the
ED with a structured and practical protocol.
ETHICAL ASPECTS
This study will be conducted according to Helsinki Declaration and i twill be approved by
our Local Ethics Committee.
AIMS OF THE STUDY
The main aim of this study was to analyze if lung ultrasound (LUS) could be a useful tool
for the early identification of heart failure in patients presenting to ED for dyspnea.
The secondary objective was to identify a protocol model for the management of acute dyspnea
on the basis of lung ultrasound pattern when added to other validated diagnostic tools.
INCLUSIONS CRITERIA
All the patients admitted to our Emergency Department from January 2011 to February 2013
with acute non-traumatic dyspnea. We included patients carried by ambulance and patients who
came autonomously.
EXCLUSIONS CRITERIA
Age <18 years
Post-traumatic dyspnea
METHODS
After triage, standardized diagnostic work-up included: 1) brief patient history (age,
gender, symptoms, medical history); 2) Vital Parameters (Blood Pressure, Heart Rate,
Arterial Oxygen Saturation, Respiratory Rate, Body Temperature); 3) 12 lead EKG; 4) Standard
laboratory assessment (NT-proBNP - ECLIA, Roche Methodics®, Creatinine, BUN, C-Reactive
Protein, Full Blood Count, Electrolytes); 5) Blood Gas Analysis. Data were collected and
stored in a database.
An independent operator performed LUS right after the admission (unaware of patient history
and vitals), then the attending physician acquired full medical history, Physical
Examination (according to Boston Criteria for Heart Failure) and requested Chest X-Ray.
Echocardiography was performed in order to validate heart failure diagnosis even if it was
not considered in our protocol because not available 24h/day in our Emergency Department.
All LUS operators were emergency physicians trained in LUS.
Lung Ultrasound We used Esaote MyLab30™ and MyLab70™ Ultrasound with Variable-Band Convex
Array (3,5-5 MHz). Six transversal scans for each hemithorax (second and fourth intercostal
space on the hemiclavear line, anterior axillar line, middle axillar line, see Figure 1).
Basal scans of the lung were sampled in order to identify pleural effusions.
We chose this anterior approach for the difficulties related to a complete evaluation of the
chest in case of severe dyspnea and non-collaborative patients.
B-lines are defined as vertical, hyperechogenic, reverberation artifacts that arise from the
pleural line to the bottom of the screen and moving synchronously with lung sliding; a
positive region is defined by the presence of three or more B-lines in a longitudinal plane
between two ribs. Acute interstitial pulmonary syndrome was defined, according to the
International Consensus Conference on LUS, as the presence of two or more positive regions
in each hemithorax.
Diagnostic Outcome (Reference Standard) Since a uniform reference test is lacking for acute
heart failure, we chose to use a consensus diagnosis as formal reference standard, in
analogy with earlier studies and as recommended by recent diagnostic research guidelines. An
independent panel of experts (made up of two cardiologists and one senior emergency
physician) judged all the collected data for each patient to determine the final diagnosis.
The panel of experts assessed acute heart failure diagnosis following the criteria and
approach outlined by the ESC Heart Failure Guidelines.
LENGHT OF THE STUDY
From January 2011 to February 2013
DATA COLLECTION
Data collection form included:
Personal data Medical hystory VItals signs; ECG; BGA; Medical Examination; Standard Blood
Test plus NT pro-BNP; Chest X-ray; Echocardiography; Lung Ultrasound
STATISTICAL ANALYSIS
Edited to Prof. Cevenini.
;
Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT02151383 -
Pharmacokinetics & Safety of Serelaxin on Top of Standard of Care Therapy in Pediatric Patients With Acute Heart Failure
|
Phase 2 | |
Completed |
NCT02135835 -
A Study to Evaluate the Efficacy and Safety of Shenfu Zhusheye in Patients With Acute Heart Failure
|
Phase 4 | |
Recruiting |
NCT05556044 -
Empagliflozin for New On-set Heart Failure Study Regardless of Ejection Fraction
|
Phase 3 | |
Recruiting |
NCT04363697 -
Dapagliflozin and Effect on Cardiovascular Events in Acute Heart Failure -Thrombolysis in Myocardial Infarction 68 (DAPA ACT HF-TIMI 68)
|
Phase 4 | |
Not yet recruiting |
NCT01211886 -
Utility of Brain Natriuretic Peptide (BNP) in Patients With Type IV Cardio-renal Syndrome Admitted to the Intensive Care Unit (ICU)
|
N/A | |
Completed |
NCT01193998 -
Impact of Validated Diagnostic Prediction Model of Acute Heart Failure in the Emergency Department
|
N/A | |
Not yet recruiting |
NCT06465498 -
Investigating aCute heArt failuRe Decongestion Guided by Lung UltraSonography
|
N/A | |
Recruiting |
NCT05276219 -
Optimized Treatment of Pulmonary Edema or Congestion
|
Phase 4 | |
Recruiting |
NCT05392764 -
Early Treatment With a Sodium-glucose Co-transporter 2 Inhibitor in High-risk Patients With Acute Heart Failure
|
Phase 3 | |
Recruiting |
NCT03157219 -
Manipal Heart Failure Registry (MHFR)
|
N/A | |
Completed |
NCT06024889 -
Acute Effects of Furosemide on Hemodynamics and Pulmonary Congestion in Acute Decompensated Heart Failure.
|
Phase 1/Phase 2 | |
Terminated |
NCT04174794 -
Investigating Reduction of aCute heArt Failure Readmission With Lung UltraSound-preliminary Trial
|
||
Recruiting |
NCT05972746 -
Telemonitoring Program in the Vulnerable Phase After Hospitalization for Heart Failure
|
N/A | |
Enrolling by invitation |
NCT02258984 -
Can the Venus 1000 Help Clinicians Treat Patients With Severe Sepsis or Acute Heart Failure? The CVP Trial
|
N/A | |
Completed |
NCT02141607 -
Evolution of Molecular Biomarkers in Acute Heart Failure Induced by Shock
|
||
Completed |
NCT01870778 -
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
|
Phase 3 | |
Recruiting |
NCT05986773 -
Diuretic Strategies in Acute Heart Failure Patients at High Risk for Diuretic Resistance
|
Phase 4 | |
Recruiting |
NCT04163588 -
Sequential Nephron Blockade in Acute Heart Failure
|
Phase 3 | |
Recruiting |
NCT04329234 -
Korean Heart Failure Registry III
|
||
Recruiting |
NCT03720288 -
Acetazolamide in Patients With Acute Heart Failure
|
Phase 3 |